CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AKER's Operating Income Growth by Quarter and Year

Akers Biosciences Inc 's Operating Income results by quarter and year




AKER Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -1.32 -2.93 -3.40
III Quarter September - -0.87 -3.12 -1.18
II Quarter June - -0.82 -2.11 -0.82
I Quarter March -3.55 -0.94 -1.89 -1.36
FY   -3.55 -3.95 -10.05 -6.76



AKER Operating Income first quarter 2020 Y/Y Growth Comment
Akers Biosciences Inc in the first quarter recorded Operating Loss of $ -3.55 millions.

According to the results reported in the first quarter, Akers Biosciences Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Akers Biosciences Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


AKER Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Akers Biosciences Inc 's first quarter 2020 Operating Income $ -3.55 millions AKER's Income Statement
Akers Biosciences Inc 's first quarter 2019 Operating Income $ -0.94 millions Quarterly AKER's Income Statement
New: More AKER's historic Operating Income Growth >>


AKER Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Akers Biosciences Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's I. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -3.55 millions by Akers Biosciences Inc look even more unfavourable if you take a look at Operating Loss -1.32 millions a quarter before.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Operating Income growth. While Akers Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AKER's I. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -3.55 millions by Akers Biosciences Inc appear even worse if you take a look at -1.32 millions a quarter before.

Within Biotechnology & Drugs industry Akers Biosciences Inc achieved highest sequential Operating Income growth. While Akers Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Akers Biosciences Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Operating Income 12 Months Ending $ -6.55 $ -3.95 $ -5.56 $ -7.82 $ -9.11
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Akers Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Akers Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AKER's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AKER's Competitors
Operating Income Growth for Akers Biosciences Inc 's Suppliers
Operating Income Growth for AKER's Customers

You may also want to know
AKER's Annual Growth Rates AKER's Profitability Ratios AKER's Asset Turnover Ratio AKER's Dividend Growth
AKER's Roe AKER's Valuation Ratios AKER's Financial Strength Ratios AKER's Dividend Payout Ratio
AKER's Roa AKER's Inventory Turnover Ratio AKER's Growth Rates AKER's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Alpha Pro Tech Ltd  326.15 %$ 326.148 millions
Molecular Templates Inc   246.92 %$ 246.921 millions
Accuray Incorporated  176.61 %$ 176.605 millions
Becton Dickinson And Company  172.06 %$ 172.059 millions
Reliv International Inc  162.58 %$ 162.585 millions
Vertex Pharmaceuticals Inc  160.19 %$ 160.189 millions
Eli Lilly And Company  146.60 %$ 146.597 millions
Nature s Sunshine Products inc   140.50 %$ 140.497 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HNRG's Profile

Stock Price

HNRG's Financials

Business Description

Fundamentals

Charts & Quotes

HNRG's News

Suppliers

HNRG's Competitors

Customers & Markets

Economic Indicators

HNRG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071